Forbes November 13, 2025
Cognito Therapeutics and West Virginia University’s Rockefeller Neuroscience Institute (RNI) have announced a strategic partnership that lays the groundwork for a new, neurotech-enabled learning healthcare system, initially focused on treating Alzheimer’s disease but aiming for much more.
The Brain Health Collaboratory is an ambitious initiative to advance science, medicine, and public health “by merging clinical care, AI-powered research, and continuous data generation.” The collaboration will harness Cognito’s treatment platform and RNI’s unique attributes to build a rural center of excellence for brain health innovation.
I spoke to Cognito’s CEO Christian Howell and RNI’s Executive Chair, Dr. Ali Rezai about their vision for this partnership and the broader headwinds driving progress in neurotechnology markets.
Cognito Therapeutics, founded in 2016 by neuroscientists...
Today's Sponsors
Today's Sponsor